The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Aguiar Eric since year 2005.
The trader's CIK number is 1262325.
At the time of the last reporting, Aguiar Eric was the Director of Eidos Therapeutics, Inc. .
(stock ticker symbol EIDX).
See this page for all insider trading activities at Eidos Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-07-03||EIDX||Eidos Therapeutics, Inc.||Buy||882,353||29.90||26,383,237|
|2019-05-24||EIDX||Eidos Therapeutics, Inc.||Buy||1,103,848||25.93||28,622,778|
|2019-02-04||BHVN||Biohaven Pharmaceutical Holding Co Ltd.||Option Ex||35,218||29.61||1,042,910|
|2007-04-12||AVNC||Advancis Pharmaceutical Corp||Buy||682,903||2.36||1,613,699|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Aguiar Eric (Director of Eidos Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.